Biomarkers of clinical benefit for anti-epidermal growth factor receptor agents in patients with non-small-cell lung cancer

Non-small-cell lung cancer (NSCLC) remains by far the major cause of cancer-related death in the Western world in both men and women. The majority of patients will be diagnosed with metastatic disease, and chemotherapy doublets remain the cornerstone of treatment for these patients. However, chemoth...

Descripción completa

Detalles Bibliográficos
Autores principales: Pallis, A G, Fennell, D A, Szutowicz, E, Leighl, N B, Greillier, L, Dziadziuszko, R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2011
Materias:
Minireview
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3137421/
https://www.ncbi.nlm.nih.gov/pubmed/21654681
http://dx.doi.org/10.1038/bjc.2011.207

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3137421/
https://www.ncbi.nlm.nih.gov/pubmed/21654681
http://dx.doi.org/10.1038/bjc.2011.207

Ejemplares similares